title: Expression of plasminogen activators in basal cell carcinoma.
abstract: The plasminogen activators, tissue type and urokinase type (tPA and uPA, respectively), have been identified in various malignancies and have been implicated in both local growth and metastatic spread. To characterize plasminogen activator expression more fully in human basal cell carcinoma, the localization of uPA and tPA mRNAs was evaluated by in situ hybridization. Nodular basal cell carcinomas demonstrated uPA expression in most cases, whereas the non-nodular subtypes were negative. Message for uPA was identified within tumour islands (11/12 cases), scattered fibroblast-like stromal cells (6/12 cases), and the basal layer of the overlying epidermis (10/12 cases). In addition, signal for uPA was elevated and pronounced in areas where the epidermis merged into invasive basal cell carcinoma in the superficial papillary dermis in some cases. Message for uPA was often associated with ulceration or erosion of the overlying epithelium. Expression of tPA was noted in the epidermis (3/12 cases) and in tumour cells (4/12 cases), but tended to be focal and sparse. These results suggest that complex interactions involving uPA expression occur between the tumour, the stroma, and the overlying epidermis. Both the stroma and the epidermis may contribute to local spread of the tumour through production of uPA and consequent plasmin-mediated activation of collagenases and metalloproteinases.
authors.affiliation: Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, USA.
authors.forename: E M
authors.initials: EM
authors.lastname: Spiers
authors.forename: G S
authors.initials: GS
authors.lastname: Lazarus
authors.forename: B
authors.initials: B
authors.lastname: Lyons-Giordano
mesh_terms: D002280:Basal Cell Carcinoma / Q000737:chemistry*; D004817:Epidermis / Q000737:chemistry; D004848:Epithelium / Q000737:chemistry; D006801:Humans; D017403:In Situ Hybridization; D010960:Plasminogen Activators / Q000032:analysis*; D012878:Skin Neoplasms / Q000737:chemistry*; D010959:Tissue Plasminogen Activator / Q000032:analysis; D014568:Urokinase-Type Plasminogen Activator / Q000032:analysis
chemical_list: D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator